- Patent covers tri-specific antibody constructs underlying CAPTN-3 modular multispecific antibody platform
- Company says Notice of Allowance strengthens CAPTN-3 program’s intellectual property protection
Wednesday, September 2, 2026
Purple Biotech USPTO Notice of Allowance for patent on tri-specific CAPTN-3 modular antibody platform
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.